This article was generated by artificial intelligence and is automatically updated as news breaks. All credit belongs to the original reporters and their publications.

The Dodgers have shut down Shohei Ohtani from pitching indefinitely, and now we know the full picture: it’s not just the left knee. Per Dodger Blue, Ohtani is also dealing with a right biceps injury that contributed to the decision to pull him from the rotation. The knee discomfort was disclosed first, and Ohtani received an Orthovisc injection designed to provide pain relief and shock absorption. But the biceps issue — now publicly confirmed — adds another layer to a situation that was already murky.

The right biceps detail matters a lot. Ohtani underwent Tommy John surgery in September 2023 and spent all of 2024 as a DH-only player before returning to the mound in 2025. Any arm-related injury for a pitcher who has already had two UCL reconstructions in his career is going to raise red flags immediately. The biceps plays a supporting role in the throwing motion, and irritation or strain there can sometimes indicate compensation patterns or lingering issues from surgical recovery. This isn’t the same as a forearm or elbow concern, but it’s not nothing — especially for a guy whose right arm has been through as much as Ohtani’s has.

His 2026 season on the mound had been a fascinating watch before this. Ohtani was pitching with the same electric stuff that made him a generational talent — the splitter remains unhittable when it’s on, and the fastball still sits in the upper 90s. But there had been whispers about his workload management and whether the Dodgers would be cautious with his innings as the season progressed. Turns out the caution was warranted for different reasons entirely.

The left knee issue, taken on its own, was manageable. The Orthovisc injection is a common treatment — it’s essentially a lubricant for the joint, used to reduce friction and pain. Plenty of athletes get these and return without incident. But stacking a knee injection on top of a biceps problem paints a picture of a pitcher whose body is telling him to stop, at least for now.

For the Dodgers, this changes the calculus heading into the trade deadline in a significant way. We were already hearing about the team’s “opportunistic mindset” at the deadline, and the pitching market just became a lot more relevant. Losing Ohtani from the rotation — even temporarily — means the Dodgers need innings, and they need them from someone who can handle high-leverage spots in October. I think this makes the reported interest in arms like Tarik Skubal even more urgent, though the price for an ace-level arm is always steep.

The DH bat stays in the lineup, obviously. Ohtani’s offensive production has been enormous this year, and that doesn’t go away. But the two-way dimension was supposed to be the Dodgers’ cheat code — getting MVP-caliber hitting and front-line pitching from one roster spot. With the mound work on hold indefinitely, that advantage is gone for now, and the front office has to find a way to replace it externally or from within. This one stings, and the “indefinitely” tag means there’s no clear timeline for his return to pitching. We’ll be watching this closely.

Source(s): Staff (Dodger Blue) | First reported: July 29, 2026 4:30 PM UTC

God Bless and Go Dodgers